BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36499141)

  • 1. Antibodies against HSV-1 and Curli Show the Highest Correlation in Parkinson's Disease Patients in Comparison to Healthy Controls.
    Jasemi S; Paulus K; Noli M; Simula ER; Ruberto S; Sechi LA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral Response to Microbial Biomarkers in Rheumatoid Arthritis Patients.
    Jasemi S; Erre GL; Cadoni ML; Bo M; Sechi LA
    J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry.
    Bo M; Erre GL; Niegowska M; Piras M; Taras L; Longu MG; Passiu G; Sechi LA
    Clin Exp Rheumatol; 2018; 36(3):376-381. PubMed ID: 29352853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.
    Cossu D; Mameli G; Galleri G; Cocco E; Masala S; Frau J; Marrosu MG; Manetti R; Sechi LA
    Mult Scler; 2015 Jul; 21(8):984-95. PubMed ID: 25392335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
    Mameli G; Cocco E; Frau J; Arru G; Caggiu E; Marrosu MG; Sechi LA
    Sci Rep; 2016 Jul; 6():29268. PubMed ID: 27383531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis in Parkinson's disease might be triggered by certain antibiotics.
    Ternák G; Kuti D; Kovács KJ
    Med Hypotheses; 2020 Apr; 137():109564. PubMed ID: 31954994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PtpA and PknG Proteins Secreted by
    Bo M; Erre GL; Bach H; Slavin YN; Manchia PA; Passiu G; Sechi LA
    J Inflamm Res; 2019; 12():301-308. PubMed ID: 31819587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
    J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
    Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
    Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Huynh VA; Takala TM; Murros KE; Diwedi B; Saris PEJ
    Front Cell Infect Microbiol; 2023; 13():1181315. PubMed ID: 37197200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
    Mameli G; Cossu D; Cocco E; Masala S; Frau J; Marrosu MG; Sechi LA
    J Neuroimmunol; 2014 May; 270(1-2):51-5. PubMed ID: 24642384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Ma LY; Gao LY; Li X; Ma HZ; Feng T
    Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma α-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.
    Ren J; Pan C; Wang Y; Xue C; Lin H; Xu J; Wang H; Zhang W; Xu P; Chen Y; Liu W
    J Neurochem; 2022 Jun; 161(6):506-515. PubMed ID: 35234288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.
    Nabizadeh F; Pirahesh K; Valizadeh P
    J Neurol; 2022 Sep; 269(9):4836-4845. PubMed ID: 35426534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
    Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
    Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?
    Arru G; Caggiu E; Paulus K; Sechi GP; Mameli G; Sechi LA
    J Neuroimmunol; 2016 Apr; 293():86-90. PubMed ID: 27049567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
    Mameli G; Madeddu G; Cossu D; Galleri G; Manetti R; Babudieri S; Mura MS; Sechi LA
    Eur J Neurol; 2016 Jan; 23(1):140-7. PubMed ID: 26453465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.